InvestorsHub Logo
Followers 33
Posts 2934
Boards Moderated 1
Alias Born 10/24/2015

Re: NY1972 post# 209

Thursday, 12/14/2023 6:08:57 PM

Thursday, December 14, 2023 6:08:57 PM

Post# of 286
Not that I'm aware. I know of a PhI/II (n=20) IIT testing an auto MAGE-C2 TCR-T in melanoma and H&N cancers with valproic acid and azacytidine https://journals.aai.org/jimmunol/article/197/6/2541/106100/MAGE-C2-Specific-TCRs-Combined-with-Epigenetic

Some years ago GSK presented this (before handing back to ADAP) https://jitc.bmj.com/content/8/Suppl_3/A60.2
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TCRX News